MACROGENICS, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $149.5M | $150.0M | $58.7M | $151.9M | $77.4M | $104.9M | $64.2M | $60.1M |
| Cost of Revenue | $0 | $847.0K | $619.0K | $3.4M | $2.7M | $0 | $0 | — |
| Gross Profit | $149.5M | $149.1M | $58.1M | $148.6M | $74.8M | $104.9M | $64.2M | — |
| Gross Margin | 100.0% | 99.4% | 98.9% | 97.8% | 96.6% | 100.0% | 100.0% | — |
| Operating Expenses | ||||||||
| Research & Development | $147.2M | $177.2M | $166.6M | $207.0M | $214.6M | $193.2M | $195.3M | $190.8M |
| SG&A Expense | $39.2M | $71.0M | $52.2M | $58.9M | $63.0M | $42.7M | $46.1M | $40.5M |
| Operating Income | $-72.8M | $-110.6M | $-168.2M | $-121.4M | $-202.8M | $-131.1M | $-177.2M | $-171.2M |
| Operating Margin | -48.7% | -73.7% | -286.4% | -79.9% | -261.9% | -125.0% | -276.0% | -284.8% |
| Interest Expense | — | $1.1M | $1.4M | $0 | $0 | — | — | — |
| Pretax Income | $-75.3M | $-66.0M | $-9.1M | $-119.8M | — | — | — | — |
| Income Tax Expense | $-672.0K | $944.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-74.6M | $-67.0M | $-9.1M | $-119.8M | $-202.1M | $-129.7M | $-151.8M | $-171.5M |
| Net Margin | -49.9% | -44.7% | -15.4% | -78.8% | -261.0% | -123.7% | -236.5% | -285.2% |
| EPS (Basic) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | $-3.16 | — |
| EPS (Diluted) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | $-3.16 | — |
| Shares Outstanding (Basic) | 63.2M | 62.6M | 61.9M | 61.4M | 59.9M | 52.4M | 48.1M | 42.4M |
| Shares Outstanding (Diluted) | 63.2M | 62.6M | 61.9M | 61.4M | 59.9M | 52.4M | 48.1M | 42.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |